Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

OBJECTIVE: Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has been recommended to treat critical coronavirus disease 2019 (COVID‐19) patients in a few reviews, but the clinical study evidence on...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Ziyun, Feng, Yongwen, Zhong, Li, Xie, Qifeng, Lei, Ming, Liu, Zheying, Wang, Conglin, Ji, Jingjing, Liu, Huiheng, Gu, Zhengtao, Hu, Zhongwei, Su, Lei, Wu, Ming, Liu, Zhifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557105/
https://www.ncbi.nlm.nih.gov/pubmed/33082954
http://dx.doi.org/10.1002/cti2.1192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557105/
https://www.ncbi.nlm.nih.gov/pubmed/33082954
http://dx.doi.org/10.1002/cti2.1192

Ejemplares similares